Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines

被引:104
作者
Velligan, Dawn I. [1 ]
Weiden, Peter J. [2 ]
Sajatovic, Martha [3 ]
Scott, Jan [4 ,5 ]
Carpenter, Daniel
Ross, Ruth [6 ]
Docherty, John P. [6 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] Univ Illinois, Chicago, IL 60680 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[6] Cornell Univ, Ithaca, NY 14853 USA
关键词
adherence; bipolar disorder; schizophrenia; medication; expert consensus guidelines; assessment; ANTIPSYCHOTIC MEDICATION ADHERENCE; RATING-SCALE MARS; BIPOLAR DISORDER; SCHIZOAFFECTIVE DISORDER; TREATMENT NONADHERENCE; PREDICTIVE-VALIDITY; SCHIZOPHRENIA; OUTPATIENTS; INDIVIDUALS; PERCEPTIONS;
D O I
10.1097/01.pra.0000367776.96012.ca
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Poor adherence to medication treatment can have devastating consequences for patients with serious mental illness. The literature review and recommendations in this article concerning assessment of adherence are reprinted from The Expert Consensus Guideline Series: Adherence Problems in Patients with Serious and Persistent Mental Illness, published in 2009. The expert consensus survey contained 39 questions (521 options) that asked about defining nonadherence, extent of adherence problems in schizophrenia and bipolar disorder, risk factors for nonadherence, assessment methods, and interventions for specific types of adherence problems. The survey was completed by 41 (85%) of the 48 experts to whom it was sent. When evaluating adherence, the experts considered it important to assess both behavior and attitude, although they considered actual behavior most important. They also noted the importance of distinguishing patients who are not willing to take medication from those who are willing but not able to take their medication as prescribed due to forgetfulness, misunderstanding of instructions, or financial or environmental problems, since this will affect the type of intervention needed. Although self- and physician report are most commonly used to clinically assess adherence, they are often inaccurate and may underestimate nonadherence. The experts believe that more accurate information will be obtained by asking about any problems patients are having or anticipate having taking medication rather than if they have been taking their medication; They also recommended speaking with family or caregivers, if the patient gives permission, as well as using more objective measures (e.g., pill counts, pharmacy records, smart pill containers if available, and, when appropriate, medication plasma levels). Use of a validated self-report scale may also help improve accuracy. For patients who appear adherent to medication, the experts recommended monthly assessments for adherence, with additional assessments if there is a noticeable symptomatic change. If there is concern about adherence, they recommended more frequent (e.g., weekly) assessments. The article concludes with suggestions for clinical interview techniques for assessing adherence. (Journal of Psychiatric Practice 2010;16:34-45)
引用
收藏
页码:34 / 45
页数:12
相关论文
共 43 条
  • [1] Classifying patients by antipsychotic adherence patterns using latent class analysis: Characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program
    Ahn, Jeonghoon
    McCombs, Jeffrey S.
    Jung, Changun
    Croudace, Tim J.
    McDonnell, David
    Ascher-Svanum, Haya
    Edgell, Eric T.
    Shi, Lizheng
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 48 - 56
  • [2] Factors associated with treatment nonadherence among US bipolar disorder patients
    Baldessarini, Ross J.
    Perry, Richard
    Pike, James
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (02) : 95 - 105
  • [3] Patients' perceptions of information received about medication prescribed for bipolar disorder: Implications for informed choice
    Bowskill, Richard
    Clatworthy, Jane
    Parham, Rhian
    Rank, Tim
    Horne, Rob
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2007, 100 (1-3) : 253 - 257
  • [4] A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia
    Byerly, M
    Fisher, R
    Whatley, K
    Holland, R
    Varghese, F
    Carmody, T
    Magouirk, B
    Rush, AJ
    [J]. PSYCHIATRY RESEARCH, 2005, 133 (2-3) : 129 - 133
  • [5] The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
    Byerly, Matthew J.
    Nakonezny, Paul A.
    Rush, A. John
    [J]. SCHIZOPHRENIA RESEARCH, 2008, 100 (1-3) : 60 - 69
  • [6] Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia
    Byerly, Matthew J.
    Thompson, Ann
    Carmody, Thomas
    Bugno, Rhiannon
    Erwin, Thomas
    Kashner, Michael
    Rush, A. John
    [J]. PSYCHIATRIC SERVICES, 2007, 58 (06) : 844 - 847
  • [7] Treatment adherence and illness insight in veterans with bipolar disorder
    Copeland, Laurel A.
    Zeber, John E.
    Salloum, Ihsan M.
    Pincus, Harold A.
    Fine, Michael J.
    Kilbourne, Amy M.
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2008, 196 (01) : 16 - 21
  • [8] Effects of ethnicity on psychotropic medications adherence
    Diaz, E
    Woods, SW
    Rosenheck, RA
    [J]. COMMUNITY MENTAL HEALTH JOURNAL, 2005, 41 (05) : 521 - 537
  • [9] Brief evaluation of medication influences and beliefs - Development and testing of a brief scale for medication adherence
    Dolder, CR
    Lacro, JP
    Warren, KA
    Golshan, S
    Perkins, DO
    Jeste, DV
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) : 404 - 409
  • [10] Assessment of compliance with antipsychotic treatment and resource utilization in a medicaid population
    Eaddy, M
    Grogg, A
    Locklear, J
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (02) : 263 - 272